Cannabis Used by Up to a Quarter of Cancer Patients
|
By HospiMedica International staff writers Posted on 05 Oct 2017 |
A new study reports that approximately 25% of cancer patients used marijuana in the past year, mostly for physical and psychological symptoms.
Researchers at Fred Hutchinson Cancer Research Center (Seattle, WA, USA) and the University of Washington (UW; Seattle, USA) conducted a cross-sectional survey among 926 patients (median age 58 years) in order to determine the prevalence and methods of use, perceived benefits, and the sources of information on cannabis for medical use; random urine samples for tetrahydrocannabinol provided survey validation. The study was conducted in Washington State, which has legalized marijuana for medicinal and recreational use.
The results revealed that a majority of the patients had a strong interest in learning about cannabis during treatment and wanted information from cancer providers. Previous use was common (66%), with 24% using cannabis in the last year, 21% using cannabis in the last month, and 18% using during the previous week, a percentage similar to that found in the random urine samples (14%). Cannabis use was primarily for physical (75%) and neuropsychiatric symptoms (63%). Legalization significantly increased the likelihood of use in more than half of the respondents. The study was published on September 25, 2017, in Cancer.
“Cancer patients desire but are not receiving information from their cancer doctors about marijuana use during their treatment, so many of them are seeking information from alternate non-scientific sources,” said lead author Steven Pergam, MD, MPH. “We hope that this study helps to open up the door for more studies aimed at evaluating the risks and benefits of marijuana in this population… because if we do not educate our patients about marijuana, they will continue to get their information elsewhere.”
Marijuana is the name given to the dried buds and leaves of varieties of the Cannabis sativa plant, and has been used in herbal remedies for centuries. The two most active components in marijuana are delta-9-tetrahydrocannabinol (THC), and cannabidiol (CBD). THC seems to cause the "high" reported by users, and also can help relieve pain and nausea and reduce inflammation. CBD can help treat seizures, reduce anxiety and paranoia, and counteract the THC high. Eight U.S. states and the District of Columbia have legalized recreational marijuana, and over half of U.S. states have passed laws allowing for medical marijuana in some form.
Related Links:
Fred Hutchinson Cancer Research Center
University of Washington
Researchers at Fred Hutchinson Cancer Research Center (Seattle, WA, USA) and the University of Washington (UW; Seattle, USA) conducted a cross-sectional survey among 926 patients (median age 58 years) in order to determine the prevalence and methods of use, perceived benefits, and the sources of information on cannabis for medical use; random urine samples for tetrahydrocannabinol provided survey validation. The study was conducted in Washington State, which has legalized marijuana for medicinal and recreational use.
The results revealed that a majority of the patients had a strong interest in learning about cannabis during treatment and wanted information from cancer providers. Previous use was common (66%), with 24% using cannabis in the last year, 21% using cannabis in the last month, and 18% using during the previous week, a percentage similar to that found in the random urine samples (14%). Cannabis use was primarily for physical (75%) and neuropsychiatric symptoms (63%). Legalization significantly increased the likelihood of use in more than half of the respondents. The study was published on September 25, 2017, in Cancer.
“Cancer patients desire but are not receiving information from their cancer doctors about marijuana use during their treatment, so many of them are seeking information from alternate non-scientific sources,” said lead author Steven Pergam, MD, MPH. “We hope that this study helps to open up the door for more studies aimed at evaluating the risks and benefits of marijuana in this population… because if we do not educate our patients about marijuana, they will continue to get their information elsewhere.”
Marijuana is the name given to the dried buds and leaves of varieties of the Cannabis sativa plant, and has been used in herbal remedies for centuries. The two most active components in marijuana are delta-9-tetrahydrocannabinol (THC), and cannabidiol (CBD). THC seems to cause the "high" reported by users, and also can help relieve pain and nausea and reduce inflammation. CBD can help treat seizures, reduce anxiety and paranoia, and counteract the THC high. Eight U.S. states and the District of Columbia have legalized recreational marijuana, and over half of U.S. states have passed laws allowing for medical marijuana in some form.
Related Links:
Fred Hutchinson Cancer Research Center
University of Washington
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







